from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3558/PPE64

LFCtreatmentdescriptionclass of inhibitor

-0.396

Amikacinug/mL Amikacintranslation

0.600

Cap5-10ug/mL Capreomycintranslation

1.333

Rox10-50 ug/mL Roxithromycintranslation

0.366

SM2-5 ug/mL Streptomycintranslation

0.755

Tet5-10 ug/mL Tetracyclinetranslation

1.455

Rif0.2-5ug/mL Rifampicintranscription

-0.532

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.352

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.944

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.048

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.590

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.449

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.719

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.186

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.133

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.738

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.562

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.226

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.876

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.584

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.035

KCN5-20 ug/mL Potassium cyaniderespiration

-1.221

NaN30.2-2 mM Sodium aziderespiration

0.147

Nigericin50 uM Nigericinrespiration

-0.616

TRC10-150 ug/mL Triclosanrespiration

-1.204

TRZ10-25 ug/mL Thioridazinerespiration

0.941

Valinomycin0.5-10 uM Valinomycinrespiration

1.109

ZnSO42 mM ZnSO4respiration

-0.731

menadione6-10 ug/mL Menadionerespiration

-0.182

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.546

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.828

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.177

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.557

NRP_1Non-replicating persistence stage 1dosRassociated

0.354

Amp0.2mg/mL AmpicillincellWall

-0.005

Cephalexin20-100 ug/mL CephalexincellWall

0.320

Cerulenin0.32-5 ug/mL CerulenincellWall

0.230

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.440

EMB10-20 ug/mL EthambutolcellWall

-0.574

Eta12-40 ug/mL EthionamidecellWall

-0.521

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.371

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.320

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.213

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.460

BZA0.12 mg/mL BenzamidearomaticAmides

0.891

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.457

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.810

H2O24 mM hydrogen peroxideDNAdamaging

-0.171

Levo10 ug/mL LevofloxacinDNAdamaging

0.642

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.665

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.017

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.745

UVUV-irradiationDNAdamaging

0.245

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.066

Antimycin12.5-50 ug/mL Antimycin A?

-1.045

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.617

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.560

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.853

PA8240.2-2 ug/mL PA-824?

-0.721

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.206

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.475

Verapamil50 uM Verapamil?

-0.795

mercaptoethanol2 mM 2-Mercaptoethanol?

0.116

methoxatin10-20 ug/mL Methoxatin?